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ABSTRACT: The ﬁrst reported examples of kinetic resolution in epoxidation reactions using iminium salt catalysis are
described, providing up to 99% ee in the epoxidation of racemic cis-chromenes.
■ INTRODUCTION
Asymmetric epoxidation of alkenes to generate optically active
epoxides is an extremely powerful synthetic tool,1 and the
development of eﬀective organocatalytic systems for epox-
idation has received considerable attention.2 The most
successful organocatalytic methods for epoxidation are those
utilizing dioxiranes and those utilizing oxaziridinium salts.
Chiral ketones, precursors to dioxiranes, such as those of Yang,3
Denmark,4 Armstrong,5 and Shi,6 have achieved high
enantioselectivities, with observed values of up to 97% ee.
Oxaziridinium salts, ﬁrst reported by Lusinchi in 1976,7 are also
reactive reagents for oxygen transfer to nucleophilic substrates,
such as sulﬁdes and alkenes, and may be generated catalytically
by use of iminium salts in the presence of a stoichiometric
oxidant, typically oxone.8
We have developed a range of catalysts for epoxidation
reactions based on biphenylazepinium (e.g., 1), binaphthylaze-
pinium (e.g., 2), and dihydroisoquinolinium (e.g., 3) moieties
containing a chiral appendage on the nitrogen atom, with the
most successful to date containing the 1,3-dioxane motif
(Figure 1).9 We have also shown that alternative oxidants may
be used in iminium salt-catalyzed epoxidation reactions, such as
hydrogen peroxide,10 sodium hypochlorite,11 and electrochemi-
cally generated oxidants.12 Amines have also been used as
iminium precursors in similar epoxidation processes by us13 and
others.14
We reported the ﬁrst very high enantioselectivities in the
asymmetric epoxidation of alkenes using iminium salt catalysts,
and we have developed nonaqueous conditions for these
processes using tetraphenylphosphonium monoperoxysulfate
(TPPP)15 as the oxidant.16 We have used the process, for
example, in the syntheses of levcromakalim 4,17 (−)-lomatin 5
and (+)-trans-khellactone 6,18 and scuteﬂorin,19 utilizing
iminium salt catalysts 1 and 3 (Figure 2). Kinetic resolution
in these iminium salt-catalyzed epoxidation processes has not
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Figure 1. Iminium salt catalysts.
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been reported, and given the high levels of enantioselectivities
observed in the epoxidation of 2-substituted benzopyrans under
our conditions, we decided to evaluate these substrates as
possible candidates for kinetic resolution using iminium salt
catalyst 3, the most enantioselective for chromene substrates.
This core structure is also found in a range of natural products,
including a number of ﬂavonoids isolated from green tea
extracts (up to 40% of the dry weight),20 such as
epigallocatechin-3-gallate (EGCG) 7 and catechin 8.
■ RESULTS AND DISCUSSION
Kinetic resolution of racemic alkenes using asymmetric
epoxidation is an attractive topic for asymmetric catalysis, as
racemic alkenes are generally cheap and readily available, but is
potentially more challenging than the asymmetric epoxidation
of prochiral alkenes. Kinetic resolution in asymmetric
epoxidation has been observed previously by Sharpless,21
Jacobsen,22 Katsuki,23 and Shi.24
We report herein the ﬁrst successful demonstration of
iminium salt-catalyzed epoxidation as a tool for kinetic
resolution of 2-substituted benzopyrans. A number of
procedures have been reported to achieve the synthesis of
2H-chromenes, including inter alia: via an allene intermediate
through a Claisen rearrangement,25 oxidation of allylphenols,26
iodination of allylphenols,27 using metal phenoxides and
carbonyls,28 using palladium catalysis,29 dehydration of
chromenols,30 using the Wittig reaction,31 using metathesis,32
and using the Petasis reaction.33 Substrates 13a−13c, 14a−14c,
15a−15c, and 16a−16c, containing the benzopyran core
structure, were prepared quickly by us in two steps using the
procedure reported by North.34 This route allows easy variation
of substituents at both the C2 and the C6 positions of the
chromenes using the corresponding dialkylacetals and phenols.
We have found diethyl acetals 9−12 to be the most reactive
substrates for this reaction, the dimethyl acetals being much less
reactive. The diethyl acetals were prepared from the
corresponding aldehydes in good yields and were subsequently
reacted with 4-chloro-, 4-cyano-, and 4-nitro-phenol to give the
corresponding chromenes 13−16 (Scheme 1, Table 1).
The chromenes were submitted to standard epoxidation
reaction conditions using m-CPBA (Scheme 2, Table 2).
Diastereoisomeric ratios (trans:cis) for the epoxide products
were obtained using 1H NMR spectroscopy carried out on the
inseparable mixture of diastereoisomers, and ranged from 1:1 to
exclusively trans with increasing bulk of the R1 substituent at
C2. Decomposition was observed when chromenes containing
a chloro R2 substituent at C6 were submitted to the epoxidation
conditions; neither the epoxides nor the corresponding diols
were isolated from the reaction mixtures.
Asymmetric epoxidation of (±)-6-cyano-2-methyl-chromene
13b under our standard nonaqueous conditions using catalyst 3
(Scheme 3) gave a promising initial result; a higher selectivity
toward the product where the methyl group at C2 is trans to
the epoxide moiety was observed compared to that observed
when m-CPBA was used. At 52% conversion, chiral HPLC and
1H NMR spectroscopic data of the mixture of inseparable
Figure 2. Levcromakalim, lomatin, khellactone, epigallocatechin-3-gallate, and catechin.
Scheme 1a
aReagents and conditions: (i) (EtO)3CH (1.2 equiv), NH4NO3 (0.25
equiv), ethanol (50 mL), 24 h, r.t.; (ii) phenol (2 equiv), 3-picoline
(0.25 equiv), p-xylene (40 mL), 16 h, reﬂux.
Table 1. Synthesis of Racemic C6-Substituted Chromenes
Scheme 2a
aReagents and conditions: (i) m-CPBA, CH2Cl2, 1−8 h, 0 °C.
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diastereoisomers showed a 3:1 diastereoisomeric ratio, 86% ee
for the major epoxide diastereoisomer 21, 97% ee for the minor
epoxide diastereoisomer 22, and 37% ee for the unreacted
starting material.
A number of chiral chromenes have previously been
synthesized as single enantiomers.35 On the basis of these
reports and the optical rotation of our recovered chromene
starting materials, we were able to assign the absolute
conﬁgurations of the products obtained. The diastereofacial
selectivity observed in the epoxidation of prochiral chromenes
using catalyst 3 corresponds to the expected outcome based on
our earlier work with this group of catalysts,17−19 providing
further conﬁrmation. Figure 3 indicates the preferred trajectory
of oxidation of these substrate types when using iminium salt 3.
Encouraged by the results obtained for compound 13b, we
tested further chiral benzopyran substrates, allowing diﬀerent
electronic and steric inﬂuences to be investigated (Table 3).
In all cases, we again found that the compounds containing
the chloro substituent on the aromatic ring were unstable to the
epoxidation reaction conditions. The best results were obtained
with compounds containing nitro and cyano substituents on
the aromatic ring. In one case, chromene 13a, the epoxidation
reaction was run for a longer reaction time, reaching 84%
conversion after 1 week. The diastereoisomeric ratio of the
product epoxides was still 2.5:1, with a 70% ee observed for the
major trans isomer and a 80% ee for the minor cis isomer. The
remaining alkene was isolated with 64% ee. As expected, the
observed krel values increase with the size of the 2-substituent in
the alkene substrates.
To conﬁrm unequivocally the absolute conﬁguration of the
major enantiomer obtained in these reactions, epoxide (+)-19b
was reductively ring-opened by hydrogenolysis over a palladium
on carbon catalyst to give alcohol 23, containing the 2-
substituted 3-hydroxybenzopyran core structure typical of the
catechins, in quantitative yield. Alcohol 23 was then converted
to the corresponding sulfonyl ester 24 by treatment with 10S-
camphorsulfonyl chloride in 43% yield (Scheme 4).
Single-crystal X-ray analysis of 24 conﬁrmed our assignment
of absolute and relative conﬁgurations (see the Supporting
Information).
■ CONCLUSION
Kinetic resolution has been shown for the ﬁrst time to be
feasible in iminium salt-catalyzed asymmetric epoxidation.
Enantioselectivities for epoxidation of racemic 2-substituted
chromene substrates were good in all cases for the major
epoxide diastereoisomer and were generally higher still for the
minor diastereoisomer, with moderate enantioselectivity
observed in the recovered starting material (15−50% ee).
Increasing the size of the 2-substituent in the chromene
substrates provided increases in diastereoselectivity and
enantioselectivity, presumably due to steric eﬀects.
■ EXPERIMENTAL SECTION
General Comments. HRMS measurements were conducted using
APCI for the ionization method and an orbitrap mass analyzer.
Enantiomeric excesses were determined by chiral high-performance
liquid chromatography using a Chiracel OD-H 5 μm particle size
column. All HPLC samples were run using hexane−isopropanol
mixtures as eluent.
General Procedure for Acetal Formation.37 The aldehyde was
dissolved in the corresponding dried alcohol (molecular sieve) (100
mL). Ammonium nitrate (0.25 equiv) and triethylorthoformate (1.2
equiv) were added to the solution. The solution was stirred under a
nitrogen atmosphere at room temperature for 24 h, and quenched with
saturated aqueous sodium hydrogen carbonate (20 mL). The mixture
was extracted using dichloromethane (4 × 20 mL), the solution dried
over magnesium sulfate, and the organic solvents were removed under
Table 2. Epoxidation of Racemic Chromenes Using m-CPBA
starting material conversion (%) epoxide epoxide d.r.
13a 100 (±)-17a 2:1
13b 100 (±)-17b 1:1
14a 100 (±)-18a 2:1
14b 100 (±)-18b 3.5:1
15a 100 (±)-19a trans only
15b 100 (±)-19b trans only
16a 81 (±)-20a 4:1
16b 80 (±)-20b 4:1
Scheme 3a
aReagents and conditions: (i) iminium salt 3 (10 mol %), TPPP (4 equiv), CHCl3, −30 °C, 24 h. NB: the upper structures of each pair are the major
enantiomers in each case
Figure 3. Directions of approach of active oxidant.
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reduced pressure. The crude acetal was puriﬁed by vacuum distillation
(35−45 °C, 2 mbar) to aﬀord a pure colorless liquid product.
General Procedure for the Formation of Chromenes. The
phenol (2 equiv) was dissolved in p-xylene, and 3-picoline (0.25 equiv)
and the corresponding acetal (1 equiv) were added. The reaction
mixture was heated under reﬂux under nitrogen for 24 h. The solvent
was removed under reduced pressure. The product was puriﬁed by
column chromatography using a petroleum ether/toluene mixture as
eluent, yielding the chromene as a pure crystalline or oily product.
General Procedure for the Formation of Racemic Epoxides.
The chromene and meta-chloroperbenzoic acid (1 equiv) were
dissolved in dichloromethane (5 mL) at 0 °C, and stirred until the
reaction reached completion. Saturated aqueous sodium hydrogen
carbonate (2 mL) was added. The organic layer was extracted with
water and brine, and the aqueous washings were extracted with further
dichloromethane. The combined organic extracts were dried over
magnesium sulfate, and solvents were removed under reduced
pressure. The crude product was puriﬁed by column chromatography
using an ethyl acetate/petroleum ether/triethylamine mixture as
eluent.
General Procedure for the Formation of Chiral Epoxides.
Tetraphenylphosphonium monoperoxysulfate (4 equiv) and iminium
salt (10 mol %) were dissolved in chloroform (20 mL per 0.1 g of
chromene) and cooled to −30 °C. The required chromene (1 equiv)
dissolved in chloroform (2 mL per 0.1 g of chromene) was then added
slowly over 10 min to the reaction mixture. The reaction progress was
monitored by 1H NMR spectroscopy of the crude reaction mixture. At
50% conversion, the reactions were quenched by the addition of
diethyl ether (20 mL per 0.1 g of chromene). The catalyst was
removed using ﬁltration through Celite and washed with diethyl ether
(10 mL per 0.1 g of chromene), and the combined organic solvents
were removed under reduced pressure. The crude product was puriﬁed
by column chromatography using an ethyl acetate/petroleum ether/
triethylamine mixture as eluent.
1,1-Diethoxybut-2-ene 9.37−39 1,1-Diethoxybut-2-ene was pre-
pared using the general procedure for acetal formation from
crotonaldehyde (10 g, 143 mmol), yielding the desired compound 9
as a colorless liquid (10.6 g, 51%) after puriﬁcation by vacuum
distillation (2 mbar, 35−38 °C). 1H NMR (300 MHz, CDCl3): δH
1.17 (6H, t, J = 7 Hz), 1.65 (3H, dd, J = 7, 2 Hz), 3.38−3.45 (2H, m),
3.50−3.61 (2H, m), 4.77 (1H, d, J = 6 Hz), 5.48 (1H, ddq, J = 16, 6, 2
Hz), 5.78 (1H, ddq, J = 16, 7, 1 Hz). 13C NMR (75 MHz, CDCl3): δC
14.9, 17.2, 60.7, 101.7, 128.9, 129.5.
(3,3-Diethoxyprop-1-enyl)benzene 10.40,41 (3,3-Diethoxy-
prop-1-enyl)benzene was prepared using the general procedure for
acetal formation from trans-cinnamaldehyde (12 g, 91 mmol), yielding
the desired compound 10 as a colorless liquid (15.6 g, 83%) after
puriﬁcation by vacuum distillation (2 mbar, 37−40 °C). 1H NMR
(300 MHz, CDCl3): δH 1.25 (6H, t, J = 7 Hz), 3.40−3.83 (4H, m),
5.06 (1H, dd, J = 5, 1 Hz), 6.21 (1H, dd, J =16, 5 Hz), 6.71 (1H, d, J =
16 Hz), 7.08−7.47 (5H, m). 13C NMR (75 MHz, CDCl3): δC 15.1,
60.9, 101.5, 126.76, 126.83, 128.0, 128.6, 132.93, 136.3.
1,1-Diethoxyhex-2-ene 11.42 1,1-Diethoxyhex-2-ene was pre-
pared using the general procedure for acetal formation from hex-2-enal
(3 g, 30.6 mmol), yielding compound 11 as a colorless liquid (2.1 g,
40%) after puriﬁcation by vacuum distillation (2 mbar, 35−37 °C). 1H
NMR (300 MHz, CDCl3): δH 0.79 (3H, t, J = 7.35 Hz), 1.09 (6H, t, J
= 7.05 Hz), 1.24−1.37 (2H, m), 1.93 (2H, dd, J = 8, 15 Hz), 3.31 −
3.51 (4H, m), 4.71 (1H, d, J = 6 Hz), 5.37 (1H, dd, J = 6, 16 Hz), 5.68
(1H, dt, J = 7, 16 Hz). 13C NMR (75 MHz, CDCl3): δC 13.3, 14.9,
21.7, 33.9, 60.6, 101.7, 127.5, 134.6.
1,1-Diethoxy-4-methylpent-2-ene 12.43 1,1-Diethoxy-4-meth-
ylpent-2-ene was prepared from 4-methyl-2-pentenal (2.0 g, 20.4
mmol), using the general procedure for acetal formation, yielding the
desired compound 12 as a pale yellow liquid (2.75 g, 78%) after
Table 3. Kinetic Resolution of Oleﬁns Using Asymmetric Epoxidation Mediated Using Catalyst 3a










13a 48 (−)-17a 2.5:1 87 97 26 2.3
13b 52 (−)-17b 3:1 86 97 37 2.9
14a 50 (−)-18a 4:1 87 98 40 3.4
14b 56 (−)-18b 3.5:1 73 92 41 2.8
15a 26 (+)-19a trans only 76 17 3.4
15b 37 (+)-19b trans only 74 14 1.9
16a 38 (−)-20a 10:1 76 82 42 8.0
16b 36 (−)-20b 16:1 88 99 50 27.9
aAll reactions were carried out with substrate (1 equiv), catalyst (10 mol %), and tetraphenylphosphonium monoperoxysulfate (TPPP) (4 equiv) in
CHCl3 at −30 °C. bConversion was determined from the 1H NMR spectra of the crude reaction mixture. cEnantioselectivity was determined using
chiral stationary phase HPLC with a Chiralcel OD-H column. dDiastereoisomeric ratios were determined from the 1H NMR spectra of the reaction
mixture after workup. ekrel = ln[(l − C)(1 − ee)]/ln[(l − C)(1 + ee)], where C is the fraction of 13, 14, 15, or 16 consumed and ee is the percentage
enantiomeric excess/100.21,22,36
Scheme 4a
aReagents and conditions: (i) Pd/C, H2 (1 atm), MeOH, r.t., 20 min, quantitative yield; (ii) (10S)-(+)-camphorsulfonyl chloride (1 equiv), Et3N (2
equiv), PhMe, r.t., 24 h, 43%.
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puriﬁcation by vacuum distillation (2 mbar, 42−45 °C). 1H NMR
(300 MHz, CDCl3): δH 0.88 (6H, d, J = 7 Hz), 1.08 (6H, t, J = 6 Hz),
2.10−2.28 (1H, m), 3.23−3.41 (2H, m), 3.40−3.55 (2H, m), 4.69
(1H, d, J = 6 Hz), 5.30 (1H, dd, J = 16, 6 Hz), 5.65 (1H, dd, J = 16, 6
Hz). 13C NMR (75 MHz, CDCl3): δC 14.5, 21.4, 30.0, 60.0, 101.3,
124.3, 140.8.
6-Nitro-2-methyl-chromene 13a.25 Compound (13a) was
prepared using the general procedure for chromene formation from
4-nitrophenol (3.19 g, 23.0 mmol) and 1,1-diethoxybut-2-ene 9 (1.65
g, 11.49 mmol), yielding compound (13a) as a yellow crystalline solid
(1.01 g, 46%; mp = 67−69 °C, lit.25 66−66.5 °C) after puriﬁcation by
column chromatography using a petroleum ether/toluene (1:1)
mixture as eluent. νmax (ﬁlm)/cm
−1: 1575, 1506, 1480, 1373, 911.
1H NMR (300 MHz, CDCl3): δH 1.49 (3H, d, J = 7 Hz), 5.14−5.22
(1H, m), 5.80 (1H, dd, J = 10, 3 Hz), 6.41 (1H, dd, J = 10, 2 Hz), 6.81
(1H, d, J = 9 Hz), 7.87 (1H, d, J = 3 Hz), 8.02 (1H, dd, J = 9, 3 Hz).
13C NMR (75 MHz, CDCl3): δC 22.0, 73.2, 116.4, 121.4, 122.3, 125.5,
128.7, 159.2. HRMS m/z: 191.0578 [M+]; C10H9NO3 requires
191.0577. HPLC trace (90:10 hexane/isopropanol, 1 mL/min); 5.7
min (48.76%), 5.97 min (51.24%).
6-Cyano-2-methyl-chromene 13b.25 Compound (13b) was
prepared using the general procedure for chromene formation from 4-
cyanophenol (1.65 g, 13.9 mmol) and 1,1-diethoxybut-2-ene 9 (1.0 g,
6.93 mmol), yielding compound (13b) as a cream solid (0.90 g, 76%;
mp = 53−55 °C, lit.25 55.5−56 °C) after puriﬁcation by column
chromatography using a petroleum ether/toluene (1:1) mixture as
eluent. νmax (ﬁlm)/cm
−1: 2360, 2342, 2225, 1605, 1488, 1373, 1253,
765. 1H NMR (400 MHz, CDCl3): δH 1.46 (3H, d, J = 7 Hz), 5.08−
5.14 (1H, m), 5.75 (1H, dd, J = 10, 3 Hz), 6.33 (1H, dd, J = 10, 2 Hz),
6.79 (1H, d, J = 8 Hz), 7.22 (1H, d, J = 2 Hz), 7.38 (1H, dd, J = 8, 2
Hz). 13C NMR (100 MHz, CDCl3): δC 21.9, 72.7, 104.2, 117.1, 119.4,
122.1, 122.3, 128.6, 130.4, 133.6, 157.3. HRMS m/z: 171.0678 [M+];
C11H9NO requires 171.0679. HPLC trace (90:10 hexane/isopropanol,
1 mL/min); 5.93 min (49.45%), 6.41 min (50.55%).
6-Chloro-2-methyl-chromene 13c.25 Compound (13c) was
prepared using the general procedure for chromene formation from 4-
chlorophenol (2.95 g, 23.04 mmol) and 1,1-diethoxybut-2-ene 9 (1.66
g, 11.52 mmol), yielding compound (13c) as a yellow liquid (0.892 g,
43%) after puriﬁcation by column chromatography using a petroleum
ether/toluene (1:1) mixture as eluent. νmax (ﬁlm)/cm
−1: 3050, 2977,
2932, 1767, 1645, 1481, 1368, 1208. 1H NMR (300 MHz, CDCl3): δH
1.44 (3H, d, J = 7 Hz), 4.95−5.03 (1H, m), 5.70 (1H, dd, J = 10, 3
Hz), 6.31 (1H, dd, J = 10, 2 Hz), 6.71 (1H, d, J = 9 Hz), 6.94 (1H, d, J
= 3 Hz), 7.05 (1H, dd, J = 9, 3 Hz). 13C NMR (75 MHz, CDCl3): δC
21.4, 71.8, 117.5, 123.0, 123.3, 125.8, 126.2, 128.4, 128.8, 152.2.
HRMS m/z: 180.0338 [M+]; C10H9ClO requires 180.0342. HPLC
trace (98:2 hexane/isopropanol, 0.5 mL/min); inseparable: 10.20 min
(100%).
6-Nitro-2-propyl-chromene 14a. Compound (14a) was pre-
pared using the general procedure for chromene formation from 4-
nitrophenol (1.0 g, 7.18 mmol) and 1,1-diethoxyhex-2-ene 11 (0.62 g,
3.59 mmol), yielding compound (14a) as a viscous orange liquid (0.7
g, 89%) after puriﬁcation by column chromatography using a
petroleum ether/toluene (1:1) mixture as eluent. νmax (ﬁlm)/cm
−1:
2961, 1614, 1580, 1515, 1483, 1342, 1242, 1091, 1002, 747. 1H NMR
(400 MHz, CDCl3): δH 0.96 (3H, t, J = 7 Hz), 1.40−1.85 (4H, m),
4.99−5.11 (1H, m), 5.79 (1H, dd, J = 10, 3 Hz), 6.40 (1H, dd, J = 10,
3 Hz), 6.79 (1H, d, J = 9 Hz), 7.84 (1H, d, J = 3 Hz), 8.00 (1H, dd, J =
9, 3 Hz). 13C NMR (100 MHz, CDCl3): 13.7, 17.7, 37.9, 76.5, 116.1,
121.5, 122.1, 123.3, 125.3, 127.6, 141.6, 159.3. HRMS m/z: 220.0962
[M + H]+; [C12H13NO3 + H]+ requires 220.0968. HPLC trace (90:10
hexane/isopropanol, 1 mL/min); 4.89 min (49.49%), 5.18 min
(50.51%).
6-Cyano-2-propyl-chromene 14b. Compound (14b) was
prepared using the general procedure for chromene formation from
4-cyanophenol (1.73 g, 14.5 mmol) and 1,1-diethoxyhex-2-ene 11
(1.25 g, 7.25 mmol), yielding compound (14b) as a straw-yellow
colored liquid (1.40 g, 97%) after puriﬁcation by column
chromatography using a petroleum ether/toluene (1:1) mixture as
eluent. νmax (ﬁlm)/cm
−1: 2960, 2874, 2225, 1605, 1489, 1381, 1253,
1130, 1005. 1H NMR (300 MHz, CDCl3): δH 0.94 (3H, t, J = 7 Hz),
1.40−1.84 (4H, m), 4.91−5.04 (1H, m), 5.74 (1H, dd, J = 10, 3 Hz),
6.33 (1H, dd, J = 10, 2 Hz), 6.77 (1H, d, J = 8 Hz), 7.19 (1H, d, J = 2
Hz), 7.35 (1H, dd, J = 8, 2 Hz). 13C NMR (75 MHz, CDCl3): δC 13.7,
17.7, 37.8, 76.0, 103.9, 116.8, 119.2, 122.2, 122.4, 127.5, 130.1, 133.4,
157.4. HRMS m/z: 200.1065 [M + H]+; [C13H13NO + H]+ requires
200.1070. HPLC trace (90:10 hexane/isopropanol, 1 mL/min); 5.11
min (50.47%), 5.47 min (49.53%).
6-Chloro-2-propyl-chromene 14c. Compound (14c) was
prepared using the general procedure for chromene formation from
4-chlorophenol (1.50 g, 11.7 mmol) and 1,1-diethoxyhex-2-ene 11
(1.0 g, 5.85 mmol), yielding compound (14c) as a yellow liquid (0.9 g,
74%) after puriﬁcation by column chromatography using a petroleum
ether/toluene (1:1) mixture as eluent. νmax (ﬁlm)/cm
−1: 2960, 2873,
1481, 1378, 1235, 1010, 878. 1H NMR (300 MHz, CDCl3): δH 0.95
(3H, t, J = 7 Hz), 1.42−1.82 (4H, m), 4.80−4.89 (1H, m), 5.72 (1H,
dd, J = 10, 3 Hz), 6.32 (1H, dd, J = 10, 2 Hz), 6.70 (1H, d, J = 9 Hz),
6.93 (1H, d, J = 3 Hz), 7.03 (1H, dd, J = 9, 3 Hz). 13C NMR (75 MHz,
CDCl3): δC 13.8, 17.9, 37.3, 75.1, 117.2, 123.0, 123.3, 125.5, 126.0,
127.3, 128.6, 152.1. HRMS m/z: 209.0722 [M + H]+; [C12H13ClO +
H]+ requires 209.0728. HPLC trace (99:1 hexane/isopropanol, 30
min, 0.5 mL/min); 7.61 min (56. 49%), 7.90 min (43.51%).
6-Nitro-2-phenyl-chromene 15a.25 Compound (15a) was
prepared using the general procedure for chromene formation from
4-nitrophenol (1.0 g, 7.2 mmol) and (3,3-diethoxyprop-1-enyl)-
benzene 10 (0.73 g, 3.56 mmol), yielding compound (15a) as a
cream solid (0.5 g, 55%; mp = 104−106 °C) after puriﬁcation by
column chromatography using a petroleum ether/toluene (3:2)
mixture as eluent. νmax (ﬁlm)/cm
−1: 3063, 3034, 1647, 1612, 1576,
1480, 1343, 1261, 913. 1H NMR (300 MHz, CDCl3): δH 5.94 (1H, dd,
J = 10, 3 Hz), 6.07 (1H, dd, J = 3, 2 Hz), 6.59 (1H, dd, J = 10, 2 Hz),
6.81 (1H, d, J = 9 Hz), 7.35−7.46 (5H, m), 7.93 (1H, d, J = 3 Hz),
8.01 (1H, dd, J = 9, 3 Hz). 13C NMR (75 MHz, CDCl3): δC 78.5,
116.3, 120.9, 122.3, 122.4, 125.6, 127.2, 129.0, 129.1, 139.5, 141.8,
158.6. m/z: 254.0799 [M + H]+; [C15H11NO3 + H]+ requires
254.0812. HPLC trace (95:5 hexane/isopropanol, 0.5 mL/min); 23.55
min (49.20%), 24.66 min (50.80%).
6-Cyano-2-phenyl-chromene 15b.44 Compound (15b) was
prepared using the general procedure for chromene formation from 4-
cyanophenol (1.0 g, 8.4 mmol) and (3,3-diethoxyprop-1-enyl)benzene
10 (0.86 g, 4.16 mmol), yielding compound (15b) as a white
crystalline powder (0.43 g, 44%; mp = 123−125 °C) after puriﬁcation
by column chromatography using a petroleum ether/toluene (1:1)
mixture as eluent. νmax (ﬁlm)/cm
−1: 3033, 2222, 1677, 1602, 1570,
1489, 1374, 1251, 1229, 1128, 893, 825. 1H NMR (300 MHz, CDCl3):
δH 5.90 (1H, dd, J = 10, 3 Hz), 6.02 (1H, dd, J = 3, 2 Hz), 6.52 (1H,
dd, J = 10, 2 Hz), 6.80 (1H, d, J = 8 Hz), 7.29 (1H, d, J = 2 Hz), 7.35−
7.45 (6H, m). 13C NMR (75 MHz, CDCl3): δC 78.0, 104.4, 117.0,
119.1, 121.7, 122.2, 126.3, 127.1, 128.9, 129.0, 130.4, 133.8, 139.7,
156.8. m/z: 251.1180 [M + NH4]+; [C16H11NO + NH4]+ requires
251.1179. HPLC trace (99.5:0.5 hexane/isopropanol, 0.5 mL/min,
230 nm); 41.34 min (47.94%), 43.47 min (52.06%).
6-Chloro-2-phenyl-chromene 15c.25 Compound (15c) was
prepared using the general procedure for chromene formation from
4-chlorophenol (1.0 g, 7.62 mmol) and (3,3-diethoxyprop-1-enyl)-
benzene 10 (0.78 g, 3.81 mmol), yielding compound (15c) as a
viscous colorless liquid (0.12 g, 13%) after puriﬁcation by column
chromatography using a petroleum ether/toluene (1:1) mixture as
eluent. νmax (ﬁlm)/cm
−1: 3032, 1639, 1477, 1424, 1368, 1261, 1231,
1200, 1121, 1034, 814, 755, 697. 1H NMR (300 MHz, CDCl3): δH
5.88 (1H, dd, J = 10, 3 Hz), 5.94 (1H, dd, J = 3, 2 Hz), 6.47 (1H, dd, J
= 10, 2 Hz), 6.72 (1H, d, J = 9 Hz), 7.02 (1H, d, J = 3 Hz), 7.08 (1H,
dd, J = 9, 3 Hz), 7.37−7.49 (5H, m). 13C NMR (75 MHz, CDCl3): δC
77.4, 117.5, 122.8, 123.3, 126.0, 126.2, 126.3, 127.2, 128.8, 128.9,
129.2, 140.4, 151.8. m/z: 243.0561 [M + H]+; [C15H11ClO + H]+
requires 243.0571. HPLC trace (99.9:0.1 hexane/isopropanol, 0.25
mL/min); inseparable: 104.77 min (100%).
6-Nitro-2-isopropyl-chromene 16a. Compound (16a) was
prepared using the general procedure for chromene formation from
4-nitrophenol (0.80 g, 5.54 mmol) and 1,1-diethoxy-4-methylpent-2-
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ene 12 (0.48 g, 2.77 mmol), yielding compound (16a) as a pale yellow
viscous oil (0.2 g, 33%) after puriﬁcation by column chromatography
using a petroleum ether/toluene (3:2) mixture as eluent. νmax (ﬁlm)/
cm−1: 3073, 2965, 2874, 1613, 1579, 1335, 1241, 1089. 1H NMR (400
MHz, CDCl3): δH 1.00 (6H, dd, J = 8, 7 Hz), 1.95−2.03 (1H, m),
4.82−4.84 (1H, m), 5.77 (1H, dd, J = 10, 3 Hz), 6.43 (1H, dd, J = 10,
2 Hz), 6.77 (1H, d, J = 9 Hz), 7.81 (1H, d, J = 3 Hz), 7.97 (1H, dd, J =
9, 3 Hz). 13C NMR (75 MHz, CDCl3): δC 17.1, 17.6, 34.2, 81.6, 115.9,
121.5, 122.2, 123.1, 125.5, 126.1, 141.5, 160.0. m/z: 237.1229 [M +
NH4]+; [C12H13NO3 + NH4]+ requires 237.1234. HPLC trace (90:10
hexane/isopropanol, 1 mL/min); 4.84 min (48.91%), 5.12 min
(51.09%).
6-Cyano-2-isopropyl-chromene 16b. Compound (16b) was
prepared using the general procedure for chromene formation from 4-
cyanophenol (0.97 g, 8.1 mmol) and 1,1-diethoxy-4-methylpent-2-ene
12 (0.7 g, 4.05 mmol), yielding compound (16b) as a colorless viscous
oil (0.25 g, 31%) after puriﬁcation by column chromatography using a
petroleum ether/toluene (3:2) mixture as eluent. νmax (ﬁlm)/cm
−1:
3053, 2965, 2931, 2874, 2225, 1603, 1489, 1379, 1252, 1130. 1H NMR
(300 MHz, CDCl3): δH 0.97 (6H, dd, J = 7, 5 Hz), 1.90−2.01 (1H,
m), 4.74−4.77 (1H, m), 5.72 (1H, dd, J = 10, 3 Hz), 6.35 (1H, dd, J =
10, 2 Hz), 6.75 (1H, d, J = 8 Hz), 7.16 (1H, d, J = 2 Hz), 7.32 (1H, dd,
J = 8, 2 Hz). 13C NMR (75 MHz, CDCl3): δC 17.1, 17.5, 33.9, 81.0,
103.7, 116.5, 119.3, 122.3, 122.9, 125.9, 130.2, 133.5, 158.0. m/z:
200.1062 [M + H]+; [C13H13NO + H]+ requires 200.1070. HPLC
trace (90:10 hexane/isopropanol, 1 mL/min); 5.02 min (49.90%),
5.42 min (50.10%).
6-Chloro-2-isopropyl-chromene 16c. Compound (16c) was
prepared using the general procedure for chromene formation from 4-
chlorophenol (1.59 g, 12.4 mmol) and 1,1-diethoxy-4-methylpent-2-
ene 12 (1.06 g, 6.2 mmol), yielding compound (16c) as a colorless oil
(0.21 g, 16%) after puriﬁcation by column chromatography using a
petroleum ether/toluene (3:2) mixture as eluent. νmax (ﬁlm)/cm
−1:
3050, 2963, 2931, 2873, 1637, 1481, 1234, 1203, 1123, 1019, 997, 878,
814, 698. 1H NMR (300 MHz, CDCl3): δH 1.00 (6H, dd, J = 7, 1 Hz),
1.93−2.04 (1H, m), 4.61−4.65 (1H, m), 5.73 (1H, dd, J = 10, 3 Hz),
6.36 (1H, dd, J = 10, 2 Hz), 6.70 (1H, d, J = 9), 6.92 (1H, d, J = 3 Hz),
7.03 (1H, dd, J = 9, 3 Hz). 13C NMR (75 MHz, CDCl3): δC 17.5, 17.6,
33.4, 80.2, 116.9, 123.3, 123.6, 125.3, 125.6, 126.0, 128.7, 152.7. HPLC
trace (99.9:0.1 hexane/isopropanol, 0.25 mL/min); 14.80 min
(49.74%), 15.87 min (50.26%).
6-Nitro-2-methyl-chromene Oxide 17a. Using General Proce-
dure A. 6-Nitro-2-methyl-chromene 13a (0.205 g, 1.07 mmol) and
meta-chloroperbenzoic acid (0.184 g, 1.07 mmol) were dissolved in
dichloromethane (40 mL) at 0 °C, and left to stir for 8 h. The racemic
epoxide was isolated as a cream solid (0.20 g, 90%; mp = 86−88 °C)
after puriﬁcation by column chromatography using a petroleum ether/
ethyl acetate/triethylamine (3:1:0.1) mixture as eluent. νmax (ﬁlm)/
cm−1: 3075, 2984, 2935, 1620, 1591, 1521, 1487, 1341, 1257, 1094,
878, 746. 1H NMR (300 MHz, CDCl3): δH 1.36 (3H, d, J = 7 Hz,
trans), 1.61 (3H, d, J = 7 Hz, cis), 3.66 (1H, dd, J = 4, 1 Hz, trans), 3.73
(1H, d, J = 4 Hz, cis), 3.95 (1H, d, J = 4 Hz, trans), 4.00 (1H, d, J = 4
Hz, cis), 4.43 (1H, q, J = 7 Hz, cis), 4.87 (1H, q, J = 7 Hz, trans), 6.90
(2H, d, J = 9 Hz, cis and trans), 8.14 (2H, dd, J = 9, 3 Hz, cis and
trans), 8.28 (1H, d, J = 3 Hz, trans), 8.31 (1H, d, J = 3 Hz, cis), (ratio
of trans:cis, 2:1). 13C NMR (75 MHz, CDCl3): δC 16.6, 18.3, 48.1,
49.5, 58.6, 58.8, 69.7, 69.9, 117.9, 118.6, 120.3, 120.6, 125.9, 126.0,
126.2, 126.4, 141.5, 141.6, 157.6, 159.4. HRMS m/z: 206.0461 [M −
H]−; [C10H9NO4 − H]− requires 206.0459. HPLC trace (99.5:0.5
hexane/isopropanol, 0.5 mL/min); 60.31 min (21.22%), 74.09 min
(21.79%), 95.06 min (28.69%), 100.87 min (28.29%).
Using General Procedure B. Tetraphenylphosphonium monoper-
oxysulfate (1.71 g, 3.8 mmol) and iminium salt 3 (0.068 g, 0.095
mmol) were dissolved in chloroform (40 mL) and cooled to −30 °C.
6-Nitro-2-methyl-chromene 13a (0.182 g, 0.95 mmol) dissolved in
chloroform (4 mL) was then added slowly over 10 min to the reaction
mixture. The reaction was quenched at 48% conversion, and
enantioenriched 6-nitro-2-methylchromene epoxide was isolated as a
cream solid (0.065 g, 33%) after puriﬁcation by column chromatog-
raphy using a petroleum ether/ethyl acetate/triethylamine (3:1:0.1)
mixture as eluent. [αD] = −58.4°, (c 0.005 g/mL CH2Cl2). HPLC
trace (99.5:0.5 hexane/isopropanol, 0.5 mL/min); 58.29 min (0.40%)
cis, 70.71 min (26.78%) cis, 91.36 min (68.02%) trans, 97.75 min
(4.79%) trans.
6-Cyano-2-methyl-chromene Epoxide 17b.30 Using General
Procedure A. 6-Cyano-2-methyl-chromene 13b (1.10 g, 6.42 mmol)
and meta-chloroperbenzoic acid (1.10 g, 6.42 mmol) were dissolved in
dichloromethane (100 mL) at 0 °C, and left to react for 6 h. The
racemic epoxide was isolated as a cream solid (1.02 g, 85%) after
puriﬁcation by column chromatography using a petroleum ether/ethyl
acetate/triethylamine (3:1:0.1) mixture as eluent. νmax (ﬁlm)/cm
−1:
2917, 2849, 2227, 1615, 1581, 1495, 1253, 1229, 1159, 873. 1H NMR
(300 MHz, CDCl3): δH 1.33 (3H, d, J = 7 Hz, trans), 1.58 (3H, d, J = 7
Hz, cis), 3.63 (1H, dd, J = 4, 1 Hz, trans), 3.69 (1H, dd, J = 4, 1 Hz,
cis), 3.87 (1H, d, J = 4 Hz, trans), 3.92 (1H, d, J = 4 Hz, cis), 4.37 (1H,
q, J = 6 Hz, cis), 4.82 (1H, q, J = 6 Hz, trans), 6.88 (2H, d, J = 9 Hz, cis
and trans), 7.52 (2H, dd, J = 9, 2 Hz, cis and trans), 7.64 (1H, d, J = 2
Hz, trans), 7.66 (1H, d, J = 2 Hz, cis). 13C NMR (75 MHz, CDCl3): δC
16.5, 18.4, 48.0, 49.4, 58.8, 59.1, 69.3, 69.5, 104.4, 104.5, 118.4, 118.7,
119.2, 121.1, 121.4, 133.9, 134.1, 134.3, 134.5, 155.7, 157.7. HRMS m/
z: 187.0628 [M+]; C11H9NO2 requires 187.0633. HPLC trace
(99.5:0.5 hexane/isopropanol, 0.5 mL/min); 76.82 min (22.87%),
119.490 min (27.75%), 127.70 min (23.05%), 137.62 min (26.33%).
Using General Procedure B. Tetraphenylphosphonium monoper-
oxysulfate (0.9 g, 2 mmol) and iminium salt 3 (0.036 g, 0.05 mmol)
were dissolved in chloroform (20 mL) and cooled to −30 °C. 6-
Cyano-2-methyl-chromene 13b (0.085 g, 0.50 mmol) dissolved in
chloroform (2 mL) was then added slowly over 10 min to the reaction
mixture. The reaction was quenched at 52% conversion, and
enantioenriched 6-cyano-2-methylchromene epoxide was isolated as
a cream solid (0.031 g, 33%; mp = 77−79 °C) after puriﬁcation by
column chromatography using a petroleum ether/ethyl acetate/
triethylamine (3:1:0.1) mixture as eluent. [αD] = −74°, (c 0.01 g/
mL CHCl3). HPLC trace (99.5:0.5 hexane/isopropanol, 0.5 mL/min);
74.88 min (0.50%) cis, 116.04 min (5.14%) trans, 125.01 min
(28.11%) cis, 132.81 min (66.26%) trans.
6-Nitro-2-propyl-chromene Epoxide 18a. Using General
Procedure A. 6-Nitro-2-propyl-chromene 14a (0.310 g, 1.43 mmol)
and meta-chloroperbenzoic acid (0.245 g, 1.43 mmol) were dissolved
in dichloromethane (50 mL) at 0 °C, and left to stir for 5 h. The
racemic epoxide was isolated as a yellow oil (0.265 g, 79%) after
puriﬁcation by column chromatography using a petroleum ether/ethyl
acetate/triethylamine (10:1:0.1) mixture as eluent. νmax (ﬁlm)/cm
−1:
2961, 2874, 1619, 1591, 1516, 1486, 1340, 1244, 1088. 1H NMR (400
MHz, CDCl3): δH 0.96 (3H, t, J = 7 Hz, trans), 1.04 (3H, t, J = 7 Hz,
cis), 1.45−2.02 (8H, m, cis and trans), 3.67 (1H, dd, J = 4, 1 Hz, trans),
3.76 (1H, dd, J = 4, 1 Hz, cis), 3.94 (1H, d, J = 4 Hz, trans), 3.99 (1H,
d, J = 4 Hz, cis), 4.26−4.30 (1H, m, cis), 4.70−4.73 (1H, m, trans),
6.91 (1H, d, J = 9 Hz, trans), 6.92 (1H, d, J = 9 Hz, cis), 8.14 (1H, dd, J
= 9, 3 Hz, cis), 8.15 (1H, dd, J = 9, 3 Hz, trans), 8.28 (1H, d, J = 3 Hz,
trans), 8.31 (1H, d, J = 3 Hz, cis), (ratio of trans:cis = 2:1). 13C NMR
(100 MHz, CDCl3): δC 14.0, 14.1, 18.4, 19.0, 33.3, 35.1, 48.6, 49.4,
58.4, 73.3, 73.6, 118.1, 118.7, 120.7, 121.1, 126.1, 126.2, 126.3, 126.6,
141.6, 141.7, 157.9, 159.6. HRMS m/z: 236.0911 [M + H]+;
[C12H13NO4 + H]+ requires 236.0918. HPLC trace (99.5:0.5 hexane/
isopropanol, 0.5 mL/min); 41.77 min (13.78%), 51.76 min (13.55%),
59.50 min (39.42%), 65.630 min (33.25%).
Using General Procedure B. Tetraphenylphosphonium monoper-
oxysulfate (2.31 g, 5.12 mmol) and iminium salt 3 (0.092 g, 0.128
mmol) were dissolved in chloroform (60 mL) and cooled to −30 °C.
6-Nitro-2-propyl-chromene 14a (0.28 g, 1.28 mmol) dissolved in
chloroform (6 mL) was then added slowly over 10 min to the reaction
mixture. The reaction was quenched at 50% conversion, and
enantioenriched 6-nitro-2-propyl-chromene epoxide was isolated as a
yellow oil (0.12 g, 40%) after puriﬁcation by column chromatography
using a petroleum ether/ethyl acetate/triethylamine (10:1:0.1)
mixture as eluent. [αD] = −35°, (c 0.01 g/mL CHCl3). HPLC trace
(99.5:0.5 hexane/isopropanol, 0.5 mL/min); 40.45 min (0.37%),
49.52 min (17.40%), 57.23 min (72.28%), 61.39 min (9.96%).
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6-Cyano-2-propyl-chromene Epoxide 18b. Using General
Procedure A. 6-Cyano-2-propyl-chromene 14b (0.150 g, 0.75
mmol) and meta-chloroperbenzoic acid (0.130 g, 0.75 mmol) were
dissolved in dichloromethane (25 mL) at 0 °C, and left to stir for 5 h.
The racemic epoxide was isolated as a colorless oil (0.13 g, 81%) after
puriﬁcation by column chromatography using a petroleum ether/ethyl
acetate/triethylamine (5:1:0.1) mixture as eluent. νmax (ﬁlm)/cm
−1:
2963, 2925, 2224, 1745, 1610, 1579, 1494, 1247, 1170. 1H NMR (400
MHz, CDCl3): δH 0.96 (3H, t, J = 7 Hz, trans), 1.03 (3H, t, J = 7 Hz,
cis), 1.45−1.85 (8H, m, cis and trans), 3.65 (1H, dd, J = 4, 1 Hz, trans),
3.74 (1H, d, J = 4 Hz, cis), 3.87 (1H, d, J = 4 Hz, trans), 3.91 (1H, d, J
= 4 Hz, cis), 4.20−4.23 (1H, m, cis), 4.66−4.69 (1H, m, trans), 6.89
(1H, d, J = 9 Hz, trans), 6.90 (1H, d, J = 9 Hz, cis), 7.52−7.55 (2H, m,
cis and trans), 7.64 (1H, d, J = 2 Hz, trans), 7.67 (1H, d, J = 2 Hz, cis)
(ratio of trans:cis, 3.5:1). 13C NMR (75 MHz, CDCl3) δC: 13.6, 13.8,
18.1, 18.6, 32.9, 34.9, 48.1, 49.0, 58.3, 72.7, 73.0, 104.5, 118.4, 118.7,
119.1, 121.7, 133.9, 134.0, 134.3, 134.6, 156.0. HRMS m/z: 238.0840
[M + Na]+; [C13H13NO2 + Na]
+ requires 238.0838. HPLC trace
(99.5:0.5 hexane/isopropanol, 0.5 mL/min); 27.14 min (10.86%),
36.32 min (38.48%), 38.24 min (10.67%), 39.82 min (39.99%).
Using General Procedure B. Tetraphenylphosphonium monoper-
oxysulfate (2.15 g, 4.76 mmol) and iminium salt 3 (0.086 g, 0.12
mmol) were dissolved in chloroform (50 mL) and cooled to −30 °C.
6-Cyano-2-propyl-chromene 14b (0.24 g, 1.19 mmol) dissolved in
chloroform (5 mL) was then added slowly over 10 min to the reaction
mixture. The reaction was quenched at 56% conversion, and
enantioenriched 6-cyano-2-propyl-chromene epoxide was isolated as
a colorless oil (0.1 g, 39%) after puriﬁcation by column
chromatography using a petroleum ether/ethyl acetate/triethylamine
(5:1:0.1) mixture as eluent. [αD] = −22°, (c 0.004 g/mL, CH2Cl2).
HPLC trace (99.5:0.5 hexane/isopropanol, 0.5 mL/min); 27.10 min
(0.93%), 36.17 min (10.56%), 37.63 min (21.42%), 39.38 min
(67.09%).
6-Nitro-2-phenyl-chromene Epoxide 19a. Using General
Procedure A. 6-Nitro-2-phenyl-chromene 15a (0.22 g, 0.87 mmol)
and meta-chloroperbenzoic acid (0.15 g, 0.87 mmol) were dissolved in
dichloromethane (40 mL) at 0 °C, and left to stir for 8 h. The racemic
epoxide was isolated as a colorless solid (0.22 g, 94%; mp = 120−122
°C) after puriﬁcation by column chromatography using a petroleum
ether/ethyl acetate/triethylamine (4:1:0.1) mixture as eluent. νmax
(ﬁlm)/cm: 3071, 2928, 1620, 1591, 1515, 1485, 1339, 1236, 1041.
1H NMR (300 MHz, CDCl3): δH 3.94 (1H, dd, J = 4, 1 Hz), 4.13 (1H,
d, J = 4 Hz), 5.73 (1H, s), 6.92 (1H, d, J = 9 Hz), 7.27−7.38 (5H, m),
8.17 (1H, dd, J = 9, 3 Hz), 8.36 (1H, d, J = 3 Hz) (only trans observed).
13C NMR (75 MHz, CDCl3) δC: 48.8, 58.1, 75.7, 100.4, 118.6, 120.7,
126.2, 126.9, 127.2, 129.4, 129.6, 136.3, 158.1. HRMS m/z: 287.1025
[M + NH4]+; [C15H11NO4 + NH4]+ requires 287.1026. HPLC trace
(90:10 hexane/isopropanol, 1 mL/min); 26.63 min (48.44%), 43.18
min (51.56%).
Using General Procedure B. Tetraphenylphosphonium monoper-
oxysulfate (3.36 g, 7.44 mmol) and iminium salt 3 (0.132 g, 0.186
mmol) were dissolved in chloroform (100 mL) and cooled to −30 °C.
6-Nitro-2-phenyl-chromene 15a (0.47 g, 1.86 mmol) dissolved in
chloroform (10 mL) was then added slowly over 10 min to the
reaction mixture. The reaction was quenched at 26% conversion, and
enantioenriched 6-nitro-2-phenyl-chromene epoxide was isolated as a
colorless solid (0.075 g, 15%) after puriﬁcation by column
chromatography using a petroleum ether/ethyl acetate/triethylamine
(4:1:0.1) mixture as eluent. [αD] = +51°, (c 0.01 g/mL, CH2Cl2);
HPLC trace (90:10 hexane/isopropanol, 1 mL/min); 23.97 min
(88.13%), 37.01 min (11.87%).
6-Cyano-2-phenyl-chromene Epoxide 19b. Using General
Procedure A. 6-Cyano-2-phenyl-chromene 15b (0.165 g, 0.71 mmol)
and meta-chloroperbenzoic acid (0.12 g, 0.71 mmol) were dissolved in
dichloromethane (30 mL) at 0 °C, and left to stir for 8 h. The racemic
epoxide was isolated as a cream solid (0.160 g, 90%) after puriﬁcation
by column chromatography using a petroleum ether/ethyl acetate/
triethylamine (4:1:0.1) mixture as eluent. νmax (ﬁlm)/cm
−1: 3057,
2903, 2223, 1610, 1577, 1491, 1242, 997. 1H NMR (300 MHz,
CDCl3) δH 3.94 (1H, dd, J = 4, 1 Hz), 4.08 (1H, d, J = 4 Hz), 5.73
(1H, s), 6.93 (1H, d, J = 9 Hz), 7.28−7.39 (5H, m), 7.58 (1H, dd, J =
9, 2 Hz), 7.74 (1H, d, J = 2 Hz) (only trans observed). 13C NMR (75
MHz, CDCl3) δC: 48.5, 58.2, 75.2, 104.7, 118.6, 118.9, 121.3, 127.0,
129.1, 129.3, 134.0, 134.8, 136.3, 156.1. HRMS m/z: 250.0859 [M +
H]+; [C16H11NO2 + H]
+ requires 250.0863. HPLC trace (90:10
hexane/isopropanol, 1 mL/min); 29.21 min (48.01%), 38.23 min
(51.99%).
Using General Procedure B. Tetraphenylphosphonium monoper-
oxysulfate (3.61 g, 8.0 mmol) and iminium salt 3 (0.144 g, 0.2 mmol)
were dissolved in chloroform (100 mL) and cooled to −30 °C. 6-
Cyano-2-phenyl-chromene 15b (0.47 g, 2.0 mmol) dissolved in
chloroform (10 mL) was then added slowly over 10 min to the
reaction mixture. The reaction was quenched at 37% conversion, and
enantioenriched 6-cyano-2-phenyl-chromene epoxide was isolated as a
cream solid (0.12 g, 24%; mp = 136−138 °C) after puriﬁcation by
column chromatography using a petroleum ether/ethyl acetate/
triethylamine (4:1:0.1) mixture as eluent. [αD] = +72°, (c 0.01 g/
mL, CH2Cl2); HPLC trace (90:10 hexane/isopropanol, 1 mL/min);
26.23 min (88.99%), 34.17 min (11.01%).
6-Nitro-2-isopropyl-chromene Epoxide 20a. Using General
Procedure A. 6-Nitro-2-isopropyl-chromene 16a (0.26 g, 1.2 mmol)
and meta-chloroperbenzoic acid (0.2 g, 1.2 mmol) were dissolved in
dichloromethane (50 mL) at 0 °C, and left to stir for 8 h. The racemic
epoxide was isolated as a yellow oil (0.14 g, 50%) after puriﬁcation by
column chromatography using a petroleum ether/ethyl acetate/
triethylamine (5:1:0.1) mixture as eluent. νmax (ﬁlm)/cm
−1: 2965,
2923, 1620, 1591, 1520, 1486, 1341, 1256, 1089. 1H NMR (400 MHz,
CDCl3): δH 0.97 (6H, d, J = 9 Hz, cis or trans), 1.09 (6H, d, J = 9 Hz,
cis or trans), 1.99−2.09 (1H, m, trans), 2.20−2.28 (1H, m, cis), 3.73
(1H, dd, J = 6, 1 Hz, trans), 3.85 (1H, d, J = 6 Hz, cis), 3.94 (1H, d, J =
6 Hz, cis), 3.96 (1H, d, J = 6 Hz, trans), 4.00 (1H, d, J = 8 Hz, cis), 4.47
(1H, d, J = 8 Hz, trans), 6.91 (1H, d, J = 12 Hz, trans), 6.94 (1H, d, J =
12 Hz, cis), 8.15 (2H, dd, J = 12, 4 Hz, C7-H, cis and trans), 8.28 (1H,
d, J = 4 Hz, trans), 8.31 (1H, d, J = 4 Hz, cis) (ratio of trans:cis, 4:1)
13C NMR (75 MHz, CDCl3): δC 18.2, 18.3, 18.4, 19.1, 31.5, 31.8, 48.5,
48.7, 56.2, 56.9, 78.1, 78.8, 117.9, 118.2, 120.6, 121.0, 126.1, 126.2,
126.3, 126.7, 141.4, 159.0, 160.2, 169.5. HRMS m/z: 236.0915 [M +
H]+; [C12H13NO4 + H]+ requires 236.0918. HPLC trace (99.5:0.5
hexane/isopropanol, 0.5 mL/min); 35.78 min (8.19%, cis), 52.39 min
(9.52%, cis), 60.19 min (41.27%, trans), 65.78 min (41.02%, trans).
Using General Procedure B. Tetraphenylphosphonium monoper-
oxysulfate (1.17 g, 2.6 mmol) and iminium salt 3 (0.046 g, 0.065
mmol) were dissolved in chloroform (30 mL) and cooled to −30 °C.
6-Nitro-2-isopropyl-chromene 16a (0.14 g, 0.65 mmol) dissolved in
chloroform (3 mL) was then added slowly over 10 min to the reaction
mixture. The reaction was quenched at 38% conversion, and
enantioenriched 6-nitro-2-isopropyl-chromene epoxide was isolated
as a yellow oil (0.035 g, 25%) after puriﬁcation by column
chromatography using a petroleum ether/ethyl acetate/triethylamine
(5:1:0.1) mixture as eluent. [αD] = −63°, (c 0.004 g/mL, CH2Cl2).
HPLC trace (99.5:0.5 hexane/isopropanol, 0.5 mL/min); 35.74 min
(0.73%, cis), 56.13 min (7.46%, cis), 63.05 min (11.07%, trans), 68.42
min (80.73%, trans).
6-Cyano-2-isopropyl-chromene Epoxide 20b. Using General
Procedure A. 6-Cyano-2-isopropyl-chromene 16b (0.29 g, 1.44 mmol)
and meta-chloroperbenzoic acid (0.25 g, 1.44 mmol) were dissolved in
dichloromethane (60 mL) at 0 °C, and left to stir for 5 h. The racemic
epoxide was isolated as a colorless oil (0.17 g, 55%) after puriﬁcation
by column chromatography using a petroleum ether/ethyl acetate/
triethylamine (5:1:0.1) mixture as eluent. νmax (ﬁlm)/cm
−1: 2967,
2932, 2877, 2226, 1616, 1582, 1495, 1251, 1134, 1008, 876. 1H NMR
(400 MHz, CDCl3): δH 0.97 (6H, d, J = 7 Hz, cis or trans), 1.08 (6H,
d, J = 7 Hz, cis or trans), 1.97−2.06 (1H, m, trans), 2.20−2.27 (1H, m,
cis), 3.72 (1H, dd, J = 4, 1 Hz, trans), 3.83 (1H, d, J = 4 Hz, cis), 3.87
(1H, d, J = 4 Hz, cis), 3.89 (1H, d, J = 4 Hz, trans), 3.95 (1H, d, J = 6
Hz, cis), 4.42 (1H, d, J = 6 Hz, trans), 6.89 (2H, d, J = 9 Hz, cis and
trans), 7.53 (2H, dd, J = 9, 2 Hz, cis and trans), 7.63 (1H, d, J = 2 Hz,
trans), 7.67 (1H, d, J = 2 Hz, cis) (ratio of trans:cis 4:1). 13C NMR
(100 MHz, CDCl3): δC 18.7, 19.3, 31.5, 48.6, 56.6, 77.8, 78.5, 118.5,
118.9, 134.2, 134.8. HRMS m/z: 216.1021 [M + H]+; [C13H13NO2 +
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H]+ requires 216.1022. HPLC trace (99.5:0.5 hexane/isopropanol, 0.5
mL/min); 42.44 min (10.10%), 64.01 min (39.00%), 80.14 min
(9.96%), 84.10 min (40.94%).
Using General Procedure B. Tetraphenylphosphonium monoper-
oxysulfate (27.4 g, 60.8 mmol) and iminium salt 3 (1.09 g, 1.52 mmol)
were dissolved in chloroform (300 mL) and cooled to −30 °C. 6-
Cyano-2-isopropyl-chromene 16b (3.0 g, 15.2 mmol) dissolved in
chloroform (30 mL) was then added slowly over 10 min to the
reaction mixture. The reaction was quenched at 36% conversion, and
enantioenriched 6-cyano-2-isopropyl-chromene epoxide was isolated
as a colorless oil (0.75 g, 23%) after puriﬁcation by column
chromatography using a petroleum ether/ethyl acetate/triethylamine
(5:1:0.1) mixture as eluent. [αD] = −52°, (c 0.01 g/mL, CH2Cl2).
HPLC trace (99.5:0.5 hexane/isopropanol, 0.5 mL/min); 43.17 min
(0.12%), 71.15 min (17.11%), 81.47 min (5.04%), 89.15 min
(77.73%).
Formation of Alcohol (+)-23.45 Epoxide (+)-19b (1 g, 4.02
mmol) was dissolved in anhydrous methanol (50 mL) in a ﬂame-dried
round-bottom ﬂask. The solution was then purged with nitrogen, and a
catalytic amount of palladium/carbon was added to the stirring
solution, followed by the addition of hydrogen gas (1 atm). The
reaction was allowed to stir at room temperature, with the reaction
progress monitored by thin-layer chromatography. Upon reaction
completion, the reaction mixture was ﬁltered through Celite, and
remaining organic solvents were removed under reduced pressure.
Alcohol 23 (1 g, 99%) was isolated as a colorless oil after column
chromatography using a petroleum ether/ethyl acetate (1:1) mixture
as eluent. [αD] = +28.0° (c 0.01 g/mL, CH2Cl2). νmax (ﬁlm)/cm
−1:
3424, 2224, 1579, 1492, 1245. 1H NMR (400 MHz, CDCl3): 1.84
(1H, d, J = 4 Hz), 2.92 (1H, dd, J = 16, 9 Hz), 3.09 (1H, dd, J = 16, 5
Hz), 4.08−4.22 (1H, m), 4.91 (1H, d, J = 8 Hz), 6.99 (1H, d, J = 8
Hz), 7.35−7.49 (7H, m). 13C NMR (100 MHz, CDCl3): 32.2, 67.4,
82.4, 104.4, 117.6, 119.1, 121.5, 126.9, 129.0, 129.1, 132.0, 134.4,
137.1, 157.7; m/z found [M + Na]+ 274.0842; [C16H13NO2 + Na]
+
requires 274.0838.
Formation of (10S)-Camphorsulfonyl Ester (+)-24.46 Alcohol
23 (1.0 g, 1 equiv, 3.98 mmol), (10S)-(+)-camphorsulfonyl chloride
(996 mg, 1 equiv, 3.98 mmol) and dry toluene (50 mL) were added to
a ﬂame-dried round-bottom ﬂask under nitrogen. To the stirring
solution, triethylamine (1.1 mL, 2 equiv, 7.96 mmol) was slowly
added, and left to stir for 24 h. Upon reaction completion, excess
organic solvents were removed under reduced pressure. Puriﬁcation by
column chromatography using a petroleum ether/ethyl acetate (6:1)
mixture as eluent aﬀorded colorless crystalline 28. Slow recrystalliza-
tion from dichloromethane/hexane aﬀorded ester 24 (6-cyano-(2R)-
phenyl-(3S)-camphor(16S,19R)-sulfonylester chromene), as long
colorless crystals (0.8 g, 43%; mp = 153−155 °C). [αD] = +44.0° (c
0.02 g/mL, CH2Cl2). νmax (ﬁlm)/cm
−1: 2963, 2226, 1743, 1493, 1246,
906, 726. 1H NMR (400 MHz, CDCl3): 0.77 (3H, s), 0.98 (3H, s),
1.35−1.41 (1H, m), 1.52−1.59 (1H, m), 1.88−2.01 (2H, m), 2.08
(1H, t, J = 4 Hz), 2.22−2.37 (2H, m), 2.65 (1H, d, J = 15 Hz), 3.11
(2H, m), 3.35 (1H, d, J = 15 Hz), 5.22−5.25 (1H, m), 5.45 (1H, d, J =
5 Hz), 7.05 (1H, d, J = 9 Hz), 7.33−7.38 (6H, m), 7.48 (1H, d, J = 9
Hz). 13C NMR (100 MHz, CDCl3): 19.6, 19.7, 24.9, 26.8, 28.9, 42.4,
42.7, 47.9, 48.3, 57.9, 75.3, 78.9, 104.7, 117.6, 118.9, 119.5, 126.0,
129.0, 129.1, 132.4, 134.2, 136.7, 157.0, 214.0; m/z found [M +
NH4]




1H and 13C NMR spectra; chromatograms and spectra for ee
determination by GC, HPLC, and NMR techniques; X-ray data
and ORTEP ﬁgure for 24, including CIF ﬁles. This material is
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